Skip to content

Dr. E. Hardeman Pneumologie

Active
Private limited companyfounded 2014active for 12 yearsLeon Fischerlaan 33, 1860 Meise, BelgiumKBO/BCE: BE 0552.633.348
Summary

Dr. E. Hardeman Pneumologie has been active since 2014 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €501,598 and a net result of €480,279. Equity is growing by about 4.9% per year across the filed financial years. Its solvency ranks better than 39% of 20,598 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow ReportCompare
Dr. E. Hardeman PneumologieActiveChecked score 93/100
Risk analysis ReportCompare

Overview

Activity
Specialist medical practice
NACE 86220
1 site
Size
€1.0mtotal assets 2025
Equity
€501,598
Profit
€480,279
Turnover not published (micro format)
Financial health
93 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
2025 accounts 57 days early2 of 3 deeds summarised
Why 93lowers riskSector: Human health activities (NACE 86)Size: total assets €1.0mFigures for financial year 2025 (filed 04-06-2026)Liquidity: current ratio 2.01, cash €206,045Show the evidence

Checked score

Score 2025
93 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 41% of its sector peers (NACE 86, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Strong
Solvency 75-25
equity 50.1% of total assets
Liquidity 53-27
short-term debt 47.1% · cash 20.6%
Profitability 100=
return on assets 47.9%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,112 companies, NACE 86, micro)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.2%▲ +0.1 percentage points vs 06-2025highest value 08-2025: < 0.1%▼ -0.2 percentage points vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026lowest value 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €45,000 on 30-day terms is acceptable
Liquidity ample (current ratio 2.01, compared with 5.38 in 2024, above the usual 1.5; short-term debt: 47.1% and cash: 20.6% of total assets), and 49.9% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 40% on solvency, 26% on liquidity, 80% on profitability and 17% on growth.

The bankruptcy probability was computed on 23-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €1.0m
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 04-06-2026)
NBB · annual accounts
lowers risk · Liquidity: current ratio 2.01, cash €206,045
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 04-06-2026, 57 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
57 days early
2024
31 days early
2023
44 days early
2022
42 days early
2021
34 days early
2020
25 days early
2019
28 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 29 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 19 June (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
24-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Highest result from 2018 to 2025net €480,279 ▲36.8%
  3. Annual accounts filedfinancial year 2024 · micro…

Key points

  • Positive: Among the best 5% on net resultsector median €60,170 · 20,585 companies €480,279 View
  • Positive: 8 profitable years in a rowprofit 2025: €480,279 8 years View
  • Caution: Equity fell in 2025from €727,436 to €501,598 ▼ 31.0% View
  • Positive: Filed on time since financial year 2020accounts within the deadline every year 6 years View

By topic

Financials

Financial year
2025
Total assets
€1.0m
Profit
€480,279
Solvency
50.1%
Total assets▲ 12.5%
Net result
20182025
Go to Financials

Timeline

Events
19
Since
2016
Next accounts
by 31-07-2027
  1. 31-12-2024Liquidity more than doubled
  2. 31-12-2024Equity above €500,000
  3. 26-06-2024Resignation: Hardeman Elke (statutory manager)
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
13-05-2014
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Key facts about Dr. E. Hardeman Pneumologie

What is the company number of Dr. E. Hardeman Pneumologie?
0552.633.348. In Belgium the VAT number is the company number with BE in front: BE 0552.633.348.
Where is Dr. E. Hardeman Pneumologie based?
The registered office is at Leon Fischerlaan 33, 1860 Meise.Company details
What does Dr. E. Hardeman Pneumologie do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. E. Hardeman Pneumologie?
Private limited company (BV).
When was Dr. E. Hardeman Pneumologie founded?
On 13-05-2014.
Is Dr. E. Hardeman Pneumologie still active?
Yes, Dr. E. Hardeman Pneumologie is an active enterprise in the KBO register.
What is the turnover of Dr. E. Hardeman Pneumologie?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is Dr. E. Hardeman Pneumologie profitable?
In financial year 2025, Dr. E. Hardeman Pneumologie made a profit of €480,279.
Where can I find the annual accounts of Dr. E. Hardeman Pneumologie?
Dr. E. Hardeman Pneumologie filed 11 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. E. Hardeman Pneumologie due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to Dr. E. Hardeman Pneumologie

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What support did similar companies receive that this one did not?Subsidies How does this company compare with its sector?Sector benchmark

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure